Submitted by Anonymous (not verified) on 27 August 2024 - 13:37
Human medicines European public assessment report (EPAR): Vitrakvi, larotrectinib, Date of authorisation: 19/09/2019, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vitrakvi, larotrectinib, Date of authorisation: 19/09/2019, Revision: 12, Status: Authorised